Transcatheter aortic valve implantation (TAVI) is associated with procedure-related stroke. Cerebral Embolic protection devices (CEPDs) are designed to reduce the risk of embolic debris reaching the brain; However, the evidence supporting their efficacy remains controversial.
(2025). Cerebral Embolic Protection Devices during TAVI: A Meta-Analysis of 11,589 Patients With Trial Sequential Analysis. Cardiovascular Research Prove Journal, 9(1), -. doi: 10.21608/cvrepj.2025.438155
MLA
. "Cerebral Embolic Protection Devices during TAVI: A Meta-Analysis of 11,589 Patients With Trial Sequential Analysis", Cardiovascular Research Prove Journal, 9, 1, 2025, -. doi: 10.21608/cvrepj.2025.438155
HARVARD
(2025). 'Cerebral Embolic Protection Devices during TAVI: A Meta-Analysis of 11,589 Patients With Trial Sequential Analysis', Cardiovascular Research Prove Journal, 9(1), pp. -. doi: 10.21608/cvrepj.2025.438155
VANCOUVER
Cerebral Embolic Protection Devices during TAVI: A Meta-Analysis of 11,589 Patients With Trial Sequential Analysis. Cardiovascular Research Prove Journal, 2025; 9(1): -. doi: 10.21608/cvrepj.2025.438155
)
View on SCiNiTO